Bausch Health Cos., Inc.(Toronto Stock Exchange : BHC)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-6.47%||23.44||14.1%||$137.92m|
|HZNP||Horizon Therapeutics Plc||-3.30%||83.57||5.4%||$110.09m|
|BHC||Bausch Health Cos., Inc.||-6.48%||23.44||0.0%||$100.89m|
|JAZZ||Jazz Pharmaceuticals Plc||-5.04%||129.86||2.1%||$83.17m|
|SAVA||Cassava Sciences, Inc.||-5.64%||34.28||0.0%||$80.72m|
|UTHR||United Therapeutics Corp.||-1.18%||197.70||13.9%||$77.94m|
|PRGO||Perrigo Co. Plc||-4.84%||36.96||6.9%||$46.83m|
|PCRX||Pacira Biosciences, Inc.||-4.79%||60.39||9.8%||$27.30m|
|BRBR||BellRing Brands, Inc.||3.65%||25.31||0.0%||$27.13m|
|IRWD||Ironwood Pharmaceuticals, Inc.||-0.28%||10.96||9.5%||$22.75m|
|SAGE||SAGE Therapeutics, Inc.||-5.18%||36.23||7.6%||$16.98m|
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.